Turkey's new alternative reimbursement legislation aims to modernize its healthcare sector by promoting innovative contracting.

It eases interactions with international pharmaceutical companies, ensures price confidentiality, and expedites product launches. However, Omar notes that companies are turning to these alternative methods due to challenges with Turkey's traditional reimbursement model, including high discounting rates. This shift is driving companies to develop more innovative contracting proposals for this alternative route.

An extract from September’s EU/UK/Asia session of Verpora's webinar series exploring the latest trends and policies surrounding Global Innovative Contracting, in EU, UK and Asia regions.

Register here for future events

Speakers

Omar Ali
Head of Payers, Verpora
LinkedIn

Adam Meads
Head of Research & Analytics, Verpora
LinkedIn